36C24519Q0620-000.docx

DOCX document 159 KB Posted

Attached to
Radiopharmaceuticals for VA Clarksburg
Solicitation number
36C24519Q0620
Issued by

About this file

36C24519Q0620 36C24519Q0620_1.docx

View the file

Other files

File Type Posted
36C24520C0026-000.docx DOCX document
36C24519Q0620-0001001.docx DOCX document

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

36C24519Q0620 FedBizOpps Combined Synopsis/Solicitation Notice

CLASSIFICATION CODE

SUBJECT

CONTRACTING OFFICE'S

ZIP-CODE

SOLICITATION NUMBER

RESPONSE DATE

(MM-DD-YYYY)

ARCHIVE

DAYS AFTER THE RESPONSE DATE

RECOVERY ACT FUNDS

SET-ASIDE

NAICS CODE

CONTRACTING OFFICE

ADDRESS

POINT OF CONTACT

(POC Information Automatically Filled from User Profile Unless Entered)

DESCRIPTION

See Attachment

AGENCY'S URL

URL DESCRIPTION

AGENCY CONTACT'S EMAIL

ADDRESS

EMAIL DESCRIPTION

ADDRESS

POSTAL CODE

COUNTRY

ADDITIONAL INFORMATION

GENERAL INFORMATION

PLACE OF PERFORMANCE

* = Required Field FedBizOpps Combined Synopsis/Solicitation Notice Rev. March 2010 Radiopharmaceuticals for VA Clarksburg 21902 36C24519Q0620 09-24-2019 N 325413 Department of Veterans Affairs VA Maryland Health Care System Contracting Officer (90C) P.O. Box 1000, Bldg. 101 Perry Point MD 21902 Rebecca Gobble Louis A Johnson VA Medical Center 1 Med Center Dr Clarksburg, WV 26301

USA

Rebecca.Gobble@va.gov See attached RFQ# 36C24519Q0620.

Responses due by 9-24-19 at 10:00 am.

Email responses to – Rebecca.Gobble@va.gov

PAGE 1 OF

1. REQUISITION NO.

2. CONTRACT NO.

3. AWARD/EFFECTIVE DATE

4. ORDER NO.

5. SOLICITATION NUMBER

6. SOLICITATION ISSUE DATE

a. NAME

b. TELEPHONE NO. (No Collect Calls)

8. OFFER DUE DATE/LOCAL

TIME

9. ISSUED BY

CODE

10. THIS ACQUISITION IS

UNRESTRICTED OR

SET ASIDE:

% FOR:

SMALL BUSINESS

HUBZONE SMALL

BUSINESS

SERVICE-DISABLED

VETERAN-OWNED

SMALL BUSINESS

WOMEN-OWNED SMALL BUSINESS

(WOSB) ELIGIBLE UNDER THE WOMEN-OWNED

SMALL BUSINESS PROGRAM

EDWOSB

8(A)

NAICS:

SIZE STANDARD:

11. DELIVERY FOR FOB DESTINA-

TION UNLESS BLOCK IS

MARKED

SEE

SCHEDULE

12. DISCOUNT TERMS

13a. THIS CONTRACT IS A

RATED ORDER UNDER

DPAS (15 CFR 700)

13b. RATING

14. METHOD OF SOLICITATION

RFQ

IFB

RFP

15. DELIVER TO

CODE

16. ADMINISTERED BY

CODE

17a. CONTRACTOR/OFFEROR

CODE

FACILITY CODE

18a. PAYMENT WILL BE MADE BY

CODE

TELEPHONE NO.

DUNS:

DUNS+4:

PHONE:

FAX:

17b. CHECK IF REMITTANCE IS DIFFERENT AND PUT SUCH ADDRESS IN OFFER 18b. SUBMIT INVOICES TO ADDRESS SHOWN IN BLOCK 18a UNLESS BLOCK

BELOW IS CHECKED

SEE ADDENDUM

19.

20.

21.

22.

23.

24.

ITEM NO.

SCHEDULE OF SUPPLIES/SERVICES

QUANTITY

UNIT

UNIT PRICE

AMOUNT

(Use Reverse and/or Attach Additional Sheets as Necessary)

25. ACCOUNTING AND

APPROPRIATION DATA

26. TOTAL AWARD AMOUNT (For Govt. Use Only) 27a. SOLICITATION INCORPORATES BY REFERENCE FAR 52.212-1, 52.212-4. FAR 52.212-3 AND 52.212-5 ARE ATTACHED. ADDENDA

ARE

ARE NOT ATTACHED.

27b. CONTRACT/PURCHASE ORDER

INCORPORATES BY REFERENCE FAR 52.212-4. FAR 52.212-5 IS ATTACHED. ADDENDA

ARE

ARE NOT ATTACHED

28. CONTRACTOR IS REQUIRED TO SIGN THIS DOCUMENT AND RETURN _______________

29. AWARD OF CONTRACT: REF. ___________________________________ OFFER

COPIES TO ISSUING OFFICE. CONTRACTOR AGREES TO FURNISH AND

DATED ________________________________. YOUR OFFER ON SOLICITATION

DELIVER ALL ITEMS SET FORTH OR OTHERWISE IDENTIFIED ABOVE AND ON ANY

(BLOCK 5), INCLUDING ANY ADDITIONS OR CHANGES WHICH ARE

ADDITIONAL SHEETS SUBJECT TO THE TERMS AND CONDITIONS SPECIFIED

SET FORTH HEREIN IS ACCEPTED AS TO ITEMS:

30a. SIGNATURE OF OFFEROR/CONTRACTOR 31a. UNITED STATES OF AMERICA (SIGNATURE OF

CONTRACTING OFFICER)

30b. NAME AND TITLE OF SIGNER (TYPE OR PRINT) 30c. DATE SIGNED 31b. NAME OF CONTRACTING OFFICER (TYPE OR PRINT) 31c. DATE SIGNED

AUTHORIZED FOR LOCAL REPRODUCTION

(REV. 2/2012)

PREVIOUS EDITION IS NOT USABLE

Prescribed by GSA - FAR (48 CFR) 53.212

7. FOR SOLICITATION

INFORMATION CALL:

STANDARD FORM 1449

OFFEROR TO COMPLETE BLOCKS 12, 17, 23, 24, & 30

SOLICITATION/CONTRACT/ORDER FOR COMMERCIAL ITEMS

540-20-1-031-0002 36C24519Q0620 09-17-2019 Rebecca Gobble 410-642-2411 x26534 09-24-2019 10:00 am Department of Veterans Affairs VA Maryland Health Care System Contracting Officer (90C) P.O. Box 1000, Bldg. 101, Room 43 Perry Point MD 21902 X 325413 1000 Employees N/A X Department of Veterans Affairs

VAMC HUNTINGTON

1540 SPRING VALLEY DR

HUNTINGTON WV 25704

Department of Veterans Affairs VA Maryland Health Care System Contracting Officer (90C) P.O. Box 1000, Bldg. 101, Room 43 Perry Point MD 21902

Department of Veterans Affairs

VAFSC

Attn: East Team Po Box 149971 Austin TX 78714 See CONTINUATION Page

RADIOPHARMACEUTICALS FOR NUCLEAR MEDICINE

BASE PLUS 4 OPTION YEARS

See CONTINUATION Page X X

REBECCA GOBBLE

CONTRACTING OFFICER

Table of Contents

SECTION A3
A.1 SF 1449 SOLICITATION/CONTRACT/ORDER FOR COMMERCIAL ITEMS3
SECTION B - CONTINUATION OF SF 1449 BLOCKS6
B.1 CONTRACT ADMINISTRATION DATA6
B.2 PRICE/COST SCHEDULE11
ITEM INFORMATIONBASE YEAR 10-1-19 to 9-30-2011
ITEM INFORMATIONOPTION YEAR ONE 10-1-20 to 9-30-2112
ITEM INFORMATIONOPTION YEAR TWO 10-1-21 to 9-30-2214
ITEM INFORMATIONOPTION YEAR THREE 10-1-22 to 9-30-2316
ITEM INFORMATIONOPTION YEAR FOUR 10-1-23 to 9-30-2417
B.3 DELIVERY SCHEDULE19
SECTION C - CONTRACT CLAUSES21
C.1 52.212-2 EVALUATION—COMMERCIAL ITEMS (OCT 2014)21
C.2 52.217-8 OPTION TO EXTEND SERVICES (NOV 1999)21
C.3 52.217-9 OPTION TO EXTEND THE TERM OF THE CONTRACT (MAR 2000)21
C.4 52.212-3 OFFEROR REPRESENTATIONS AND CERTIFICATIONS—COMMERCIAL ITEMS (OCT 2018) ALTERNATE I (OCT 2014)22
C.5 52.232-18 AVAILABILITY OF FUNDS (APR 1984)35
C.6 52.232-19 AVAILABILITY OF FUNDS FOR THE NEXT FISCAL YEAR (APR 1984)35
C.7 52.237-3 CONTINUITY OF SERVICES (JAN 1991)35
C.8 VAAR 852.215-71 EVALUATION FACTOR COMMITMENTS (DEC 2009)36
C.9 VAAR 852.219-74 LIMITATIONS ON SUBCONTRACTING—MONITORING AND COMPLIANCE (JUL 2018)36
C.10 VAAR 852.219-75 SUBCONTRACTING COMMITMENTS MONITORING AND COMPLIANCE (JUL 2018)36
C.11 VAAR 852.232-72 ELECTRONIC SUBMISSION OF PAYMENT REQUESTS (NOV 2018)37
C.12 VAAR 852.252-70 SOLICITATION PROVISIONS OR CLAUSES INCORPORATED BY REFERENCE (JAN 2008)38
C.13 VAAR 852.203-70 COMMERCIAL ADVERTISING (MAY 2018)38
C.14 52.212-5 CONTRACT TERMS AND CONDITIONS REQUIRED TO IMPLEMENT STATUTES OR EXECUTIVE ORDERS—COMMERCIAL ITEMS (MAY 2019)38
SECTION D - CONTRACT DOCUMENTS, EXHIBITS, OR ATTACHMENTS45
SECTION E - SOLICITATION PROVISIONS46
E.1 52.212-1 INSTRUCTIONS TO OFFERORS—COMMERCIAL ITEMS (OCT 2018)46
E.2 52.212-3 OFFEROR REPRESENTATIONS AND CERTIFICATIONS—COMMERCIAL ITEMS (OCT 2018)49
E.3 52.216-1 TYPE OF CONTRACT (APR 1984)62
E.4 52.233-2 SERVICE OF PROTEST (SEP 2006)62
E.5 VAAR 852.215-70 SERVICE-DISABLED VETERAN-OWNED AND VETERAN-OWNED SMALL BUSINESS EVALUATION FACTORS (JUL 2016)(DEVIATION)62
E.6 52.203-17 CONTRACTOR EMPLOYEE WHISTLEBLOWER RIGHTS AND REQUIREMENT TO INFORM EMPLOYEES OF WHISTLEBLOWER RIGHTS (APR 2014)63
E.7 VAAR 852.233-70 PROTEST CONTENT/ALTERNATIVE DISPUTE RESOLUTION (OCT 2018)63
E.8 VAAR 852.233-71 ALTERNATE PROTEST PROCEDURE (OCT 2018)64
E.9 VAAR 852.237-70 CONTRACTOR RESPONSIBILITIES (APR 1984)64
E.10 52.252-1 SOLICITATION PROVISIONS INCORPORATED BY REFERENCE (FEB 1998)64
E.11 52.204-16 COMMERCIAL AND GOVERNMENT ENTITY CODE REPORTING (JUL 2016)64
E.12 52.209-5 CERTIFICATION REGARDING RESPONSIBILITY MATTERS (OCT 2015)65
E.13 VAAR 852.246-71 REJECTED GOODS (OCT 2018)67
E.14 VAAR 852.246-71 INSPECTION (2008) ALTERNATE I (JAN 2008)67

SECTION B - CONTINUATION OF SF 1449 BLOCKS

B.1 CONTRACT ADMINISTRATION DATA

1. Contract Administration: All contract administration matters will be handled by the following individuals:

a. CONTRACTOR:_____________________________
______________________________
______________________________
______________________________

b. GOVERNMENT: Department of Veterans Affairs VA Maryland Health Care System Rebecca Gobble, Contracting Officer (90C) P.O. Box 1000, Bldg. 101, Room 43 Perry Point MD 21902 Rebecca.Gobble@va.gov

2. CONTRACTOR REMITTANCE ADDRESS: All payments by the Government to the contractor will be made in accordance with:

[X]
52.232-33, Payment by Electronic Funds Transfer—System For Award Management, or
[]
52.232-36, Payment by Third Party

3. INVOICES: Invoices shall be submitted in arrears:

a. Quarterly[]
b. Semi-Annually[]
c. Other[X]

4. GOVERNMENT INVOICE ADDRESS: All Invoices from the contractor shall be submitted electronically in accordance with VAAR Clause 852.232-72 Electronic Submission of Payment Requests.

Department of Veterans Affairs

VAFSC

Attn: East Team Po Box 149971 Austin TX 78714 ACKNOWLEDGMENT OF AMENDMENTS: The offeror acknowledges receipt of amendments to the Solicitation numbered and dated as follows:

AMENDMENT NO
DATE
RFQ for Radiopharmaceuticals
STATEMENT OF WORK
Louis A Johnson VA Medical Center
1 Med Center Dr
Clarksburg, WV 26301

A contract is being sought for acquisition of radiopharmaceuticals. These products will be used for human administration during diagnostic nuclear medicine studies.

DESCRIPTION OF SERVICES / REQUIREMENTS

1. Normally orders shall be placed mid to late work day and delivery shall be no later than 7:30 am the following work day. Due to the demands of the Medical Center care requirements; there shall be no restriction to the number of orders which may be placed by VA or the number of delivers which may be required per day. In the event that the requirements may be determined in advance, a longer delivery time will be scheduled accordingly.

2. Depending upon the availability of the product, the Contractor shall make deliveries within two (2) hours when orders are placed during business hours, 7:30 am to 4:30 pm Monday through Friday.

3. The Contractor will provide 24 hour on call service for emergent procedures, both within and outside of normal business hours. Times designated as outside of normal business hours are:

a. Monday through Friday from 4:30 pm to 7:30 am

b. Weekends from Friday at 4:30 pm until Monday at 7:30 am

c. Federal holidays

· New Year’s Day

· Martin Luther King Day

· President’s Day

· Memorial Day

· Independence Day

· Labor Day

· Columbus Day

· Veterans’ Day

· Thanksgiving Day

· Christmas Day

· In addition, any other day specifically declared by the President of the United States is considered to be a federal holiday. It should be noted, if a holiday falls on Saturday, it is observed on Friday. If a holiday falls on Sunday, it is observed on Monday.

4. Orders can be placed orally by telephone and/or facsimile transmission.

5. The Contractor will provide two (2) 10mCi Cobalt 57 sheet sources per year, as listed in the Schedule of Supplies section of this document. The used sheet sources will be removed from the nuclear medicine area and disposed of by the Contractor. The sheet source will measure approximately 25 inches by 18 inches, but is dependent upon the make and model of gamma camera in use at the time.

6. All products provided under this contract shall meet all requirements of the Nuclear Regulatory Commission. All products provided under this contract shall be packaged and shipped in accordance with the requirements of the Nuclear Regulatory Commission and Department of Transportation (DOT). All products returned will also be packaged in accordance with the requirements of the Nuclear Regulatory Commission and the Department of Transportation.

7. All packaging of radioactive material must be clearly labeled RADIOACTIVE on the outside of the shipping carton.

8. In addition, the Contractor will comply with all OSHA manufacturing, packaging and shipping regulations is required.

9. The Contractor will submit invoices monthly, in arrears, for all products delivered since the previous billing cycle. Invoices will be submitted electronically via the OB10 website.

10. All shipping containers will be returned to the Contractor.

11. The Contractor will provide reimbursement for unused cardiac Technetium based doses, i.e. Myoview, Cardiolite, and their generics.

QUALITY CONTROL

1. The Contractor will perform all quality control procedures as required by Federal and State regulatory agencies.

2. The contractor shall guarantee the quality of all radiopharmaceuticals. Quality control shall include percent tag and MO99 breakthrough as appropriate. The Contractor shall provide Quality Control on each agent dispensed. The Contractor shall guarantee the quality of all radiopharmaceuticals. The Contractor shall provide complete documentation on Quality Control results upon request.

3. The contractor shall provide a quarterly linearity source, as listed in the Schedule of Supplies section of this document. The activity requested can range from 25 to 100mCi.

4. RECALLED AND DEFECTIVE PRODUCTS: The Contractor will immediately notify the Contracting Officer’s Representative (COR) and/or the Imaging Service Supervisor of any product recalls or other important product safety issues. As appropriate, the Contractor will replace and/or reimburse recalled/defective products at no cost to the Government. The Contractor may be liable for the cost of processing recalls, i.e. administrative and clinical services to replace recalled/defective products.

QUALIFICATIONS

The Contractor must be licensed by the Nuclear Regulatory Commission and be regularly established in the business of providing radiopharmaceuticals for medical use.

TERM OF CONTRACT

This contract is effective for five (5) years from date of award. The contract is subject to the availability of funds. The Contractor shall perform no services after September 30 of any year until the Contracting Officer authorizes such services in writing.

RECORD KEEPING

1. The Contractor shall provide computer hardware and software to support a nuclear medicine information management system. This information system shall provide inventory, disposal, patient dose records and documents in compliance with Nuclear Regulatory Commission requirements. The Contractor will provide all software and hardware upgrades/updates on computer systems.

2. The Contractor shall label all supplies as to the amount of radiopharmaceutical, preparation time, expiration time, date, etc., and provide a bar label to allow scanning data into a nuclear medicine information management system.

SCHEDULE OF SUPPLIES

1. The Contractor shall provide items on a unit dose basis, pre-drawn into a syringe, calibrated and delivered to the Nuclear Medicine department of the Louis A. Johnson Veterans Affairs Medical Center, #1 Medical Center Drive, Clarksburg, West Virginia. Items will be required Monday through Friday during the hours of 7:00am to 4:30pm, as well as on an as needed basis.

2. Quantities listed are estimated usage only.

3. The Contractor will provide other radiopharmaceuticals, which are not listed here, when/if the need arises. This list is not exhaustive, but contains the most common radiopharmaceuticals used at this facility.

Line Item
Product
How Supplied
Estimated Quantity
Unit Price

Unit Doses

0001
HDP
per dose
92
0002
MAA
per dose
30
0003
DTPA
per dose
30
0004
Mebrofenin
per dose
65
0005
Sulfur Colloid
per dose
65
0006
MAG-3
per dose
10
0007
Sestamibi
per dose
2200
0008
Tc-99m
per 1 mCi
1000
0009
In-111-Octreoscan
per dose
1
0010
Thallium-201
per mCi
0
0011
Gallium-67
per mCi
0
0012
I-123 (100uCi)
per capsule
0013
I-123 (200uCi)
per capsule
35
0014
Sulfur Colloid (Filtered)
per dose
12
0015
10mCi Cobalt57 Sheet Source
each
2
0016
MDP
per dose
234

Therapy

0017
I-131 Therapy Capsule
per first mCi
1
0018
I-131 Therapy Capsule
each additional mCi
32

White Blood Cells

0019
In-111 WBC
per study
1
0020
Exametazime
per study
20
0021
Blood Handling
per occurrence

Cold Kits

0022
Choletec
per vial
25
0023
Hepatolite
per vial
0024
DTPA
per vial
0025
HDP
per vial
0026
MAA
per vial
0027
PYP
per vial
25
0028
Sulfur Colloid
per vial
0029
Kinevac
per 10 vials
0030
Ultratag
per vial
10

Incidentals

0031
Persantine
0032
Lexiscan
per dose
0033
Dobutamine
0034
Lasix
per vial
0035
Metastron Sr-89
per 4 mCi dose
0036
Quadramet
per dose
0037
In-111 DTPA
per vial
0038
Neurolite
per dose
BASE YEAR10-1-2019 to 9-30-2020_____________________
OPTION YEAR ONE10-1-2020 to 9-30-2021_____________________
OPTION YEAR TWO10-1-2021 to 9-30-2022_____________________
OPTION YEAR THREE10-1-2022 to 9-30-2023_____________________
OPTION YEAR FOUR10-2-2023 to 9-30-2024_____________________

GRAND TOTAL ______________________

B.2 PRICE/COST SCHEDULE

ITEM INFORMATIONBASE YEAR 10-1-19 to 9-30-20
ITEM NUMBER
DESCRIPTION OF SUPPLIES/SERVICES
QUANTITY
UNIT
UNIT PRICE
AMOUNT
92.00
EA
__________________
__________________

HDP (per dose)

30.00
EA
__________________
__________________

MAA (per dose)

30.00
EA
__________________
__________________

DTPA (per dose)

65.00
EA
__________________
__________________

Mebrofenin (per dose)

65.00
EA
__________________
__________________

Sulfur Colloid (per dose)

10.00
EA
__________________
__________________

MAG-3 (per dose)

2,200.00
EA
__________________
__________________

Sestamibi (per dose)

1,000.00
EA
__________________
__________________

Tc-99m (per 1 mCi)

1.00
EA
__________________
__________________

On-111-Octreoscan (per dose)

35.00
EA
__________________
__________________

I-123 (200uCi) (per capsule)

12.00
EA
__________________
__________________

Sulfur Colloid (Filtered) (per dose)

2.00
EA
__________________
__________________

10mCi Cobalt57 Sheet Source (each)

234.00
EA
__________________
__________________

MDP (per dose)

1.00
EA
__________________
__________________

I-131 Therapy Capsule (per first mCi)

32.00
EA
__________________
__________________

I-131 Therapy Capsule (each additional mCi)

1.00
EA
__________________
__________________

In-111 WBC (per study)

20.00
EA
__________________
__________________

Exametazime (per study)

20.00
EA
__________________
__________________

Blood Handling (per occurrence)

25.00
EA
__________________
__________________

Choletec (per vial)

25.00
EA
__________________
__________________

PYP (per vial)

10.00
EA
__________________
__________________

Ultratag (per vial)

GRAND TOTAL
__________________
ITEM INFORMATIONOPTION YEAR ONE 10-1-20 to 9-30-21
ITEM NUMBER
DESCRIPTION OF SUPPLIES/SERVICES
QUANTITY
UNIT
UNIT PRICE
AMOUNT
92.00
EA
__________________
__________________

HDP (per dose)

30.00
EA
__________________
__________________

MAA (per dose)

30.00
EA
__________________
__________________

DTPA (per dose)

65.00
EA
__________________
__________________

Mebrofenin (per dose)

65.00
EA
__________________
__________________

Sulfur Colloid (per dose)

10.00
EA
__________________
__________________

MAG-3 (per dose)

2,200.00
EA
__________________
__________________

Sestamibi (per dose)

1,000.00
EA
__________________
__________________

Tc-99m (per 1 mCi)

1.00
EA
__________________
__________________

On-111-Octreoscan (per dose)

35.00
EA
__________________
__________________

I-123 (200uCi) (per capsule)

12.00
EA
__________________
__________________

Sulfur Colloid (Filtered) (per dose)

2.00
EA
__________________
__________________

10mCi Cobalt57 Sheet Source (each)

234.00
EA
__________________
__________________

MDP (per dose)

1.00
EA
__________________
__________________

I-131 Therapy Capsule (per first mCi)

32.00
EA
__________________
__________________

I-131 Therapy Capsule (each additional mCi)

1.00
EA
__________________
__________________

In-111 WBC (per study)

20.00
EA
__________________
__________________

Exametazime (per study)

20.00
EA
__________________
__________________

Blood Handling (per occurrence)

25.00
EA
__________________
__________________

Choletec (per vial)

25.00
EA
__________________
__________________

PYP (per vial)

10.00
EA
__________________
__________________

Ultratag (per vial)

GRAND TOTAL
__________________
ITEM INFORMATIONOPTION YEAR TWO 10-1-21 to 9-30-22
ITEM NUMBER
DESCRIPTION OF SUPPLIES/SERVICES
QUANTITY
UNIT
UNIT PRICE
AMOUNT
92.00
EA
__________________
__________________

HDP (per dose)

30.00
EA
__________________
__________________

MAA (per dose)

30.00
EA
__________________
__________________

DTPA (per dose)

65.00
EA
__________________
__________________

Mebrofenin (per dose)

65.00
EA
__________________
__________________

Sulfur Colloid (per dose)

10.00
EA
__________________
__________________

MAG-3 (per dose)

2,200.00
EA
__________________
__________________

Sestamibi (per dose)

1,000.00
EA
__________________
__________________

Tc-99m (per 1 mCi)

1.00
EA
__________________
__________________

On-111-Octreoscan (per dose)

35.00
EA
__________________
__________________

I-123 (200uCi) (per capsule)

12.00
EA
__________________
__________________

Sulfur Colloid (Filtered) (per dose)

2.00
EA
__________________
__________________

10mCi Cobalt57 Sheet Source (each)

234.00
EA
__________________
__________________

MDP (per dose)

1.00
EA
__________________
__________________

I-131 Therapy Capsule (per first mCi)

32.00
EA
__________________
__________________

I-131 Therapy Capsule (each additional mCi)

1.00
EA
__________________
__________________

In-111 WBC (per study)

20.00
EA
__________________
__________________

Exametazime (per study)

20.00
EA
__________________
__________________

Blood Handling (per occurrence)

25.00
EA
__________________
__________________

Choletec (per vial)

25.00
EA
__________________
__________________

PYP (per vial)

10.00
EA
__________________
__________________

Ultratag (per vial)

GRAND TOTAL
__________________
ITEM INFORMATIONOPTION YEAR THREE 10-1-22 to 9-30-23
ITEM NUMBER
DESCRIPTION OF SUPPLIES/SERVICES
QUANTITY
UNIT
UNIT PRICE
AMOUNT
92.00
EA
__________________
__________________

HDP (per dose)

30.00
EA
__________________
__________________

MAA (per dose)

30.00
EA
__________________
__________________

DTPA (per dose)

65.00
EA
__________________
__________________

Mebrofenin (per dose)

65.00
EA
__________________
__________________

Sulfur Colloid (per dose)

10.00
EA
__________________
__________________

MAG-3 (per dose)

2,200.00
EA
__________________
__________________

Sestamibi (per dose)

1,000.00
EA
__________________
__________________

Tc-99m (per 1 mCi)

1.00
EA
__________________
__________________

On-111-Octreoscan (per dose)

35.00
EA
__________________
__________________

I-123 (200uCi) (per capsule)

12.00
EA
__________________
__________________

Sulfur Colloid (Filtered) (per dose)

2.00
EA
__________________
__________________

10mCi Cobalt57 Sheet Source (each)

234.00
EA
__________________
__________________

MDP (per dose)

1.00
EA
__________________
__________________

I-131 Therapy Capsule (per first mCi)

32.00
EA
__________________
__________________

I-131 Therapy Capsule (each additional mCi)

1.00
EA
__________________
__________________

In-111 WBC (per study)

20.00
EA
__________________
__________________

Exametazime (per study)

20.00
EA
__________________
__________________

Blood Handling (per occurrence)

25.00
EA
__________________
__________________

Choletec (per vial)

25.00
EA
__________________
__________________

PYP (per vial)

10.00
EA
__________________
__________________

Ultratag (per vial)

GRAND TOTAL
__________________
ITEM INFORMATIONOPTION YEAR FOUR 10-1-23 to 9-30-24
ITEM NUMBER
DESCRIPTION OF SUPPLIES/SERVICES
QUANTITY
UNIT
UNIT PRICE
AMOUNT
92.00
EA
__________________
__________________

HDP (per dose)

30.00
EA
__________________
__________________

MAA (per dose)

30.00
EA
__________________
__________________

DTPA (per dose)

65.00
EA
__________________
__________________

Mebrofenin (per dose)

65.00
EA
__________________
__________________

Sulfur Colloid (per dose)

10.00
EA
__________________
__________________

MAG-3 (per dose)

2,200.00
EA
__________________
__________________

Sestamibi (per dose)

1,000.00
EA
__________________
__________________

Tc-99m (per 1 mCi)

1.00
EA
__________________
__________________

On-111-Octreoscan (per dose)

35.00
EA
__________________
__________________

I-123 (200uCi) (per capsule)

12.00
EA
__________________
__________________

Sulfur Colloid (Filtered) (per dose)

2.00
EA
__________________
__________________

10mCi Cobalt57 Sheet Source (each)

234.00
EA
__________________
__________________

MDP (per dose)

1.00
EA
__________________
__________________

I-131 Therapy Capsule (per first mCi)

32.00
EA
__________________
__________________

I-131 Therapy Capsule (each additional mCi)

1.00
EA
__________________
__________________

In-111 WBC (per study)

20.00
EA
__________________
__________________

Exametazime (per study)

20.00
EA
__________________
__________________

Blood Handling (per occurrence)

25.00
EA
__________________
__________________

Choletec (per vial)

25.00
EA
__________________
__________________

PYP (per vial)

10.00
EA
__________________
__________________

Ultratag (per vial)

GRAND TOTAL
__________________

B.3 DELIVERY SCHEDULE

ITEM NUMBER
QUANTITY
DELIVERY DATE

92.00

30.00

30.00

65.00

65.00

10.00

2,200.00

1,000.00

1.00

35.00

12.00

2.00

234.00

1.00

32.00

1.00

20.00

20.00

25.00

25.00

10.00

36C24519Q0620

Page 1 of Page 1 of Page 1 of Page 1 of

SECTION C - CONTRACT CLAUSES

C.1 52.212-2 EVALUATION—COMMERCIAL ITEMS (OCT 2014)

(a) The Government will award a contract resulting from this solicitation to the responsible offeror whose offer conforming to the solicitation will be most advantageous to the Government, price and other factors considered. The following factors shall be used to evaluate offers:

1. The Contractor must be licensed by the Nuclear Regulatory Commission and be regularly established in the business of providing radiopharmaceuticals for medical use.

2. Contractor must be located close enough to provide items in a 2 hour period if required

3. Contractor must be able to provide all items listed in SOW.

4. Items must all come from the same lab.

Technical and past performance, when combined, are more important than price.

(b) Options. The Government will evaluate offers for award purposes by adding the total price for all options to the total price for the basic requirement. The Government may determine that an offer is unacceptable if the option prices are significantly unbalanced. Evaluation of options shall not obligate the Government to exercise the option(s).

(c) A written notice of award or acceptance of an offer, mailed or otherwise furnished to the successful offeror within the time for acceptance specified in the offer, shall result in a binding contract without further action by either party. Before the offer's specified expiration time, the Government may accept an offer (or part of an offer), whether or not there are negotiations after its receipt, unless a written notice of withdrawal is received before award.

(End of Provision)

FAR Number
Title
Date
52.212-4
CONTRACT TERMS AND CONDITIONS—COMMERCIAL ITEMS
OCT 2018

ADDENDUM to FAR 52.212-4 CONTRACT TERMS AND CONDITIONS—COMMERCIAL ITEMS Clauses that are incorporated by reference (by Citation Number, Title, and Date), have the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available.

The following clauses are incorporated into 52.212-4 as an addendum to this contract:

C.2 52.217-8 OPTION TO EXTEND SERVICES (NOV 1999)

The Government may require continued performance of any services within the limits and at the rates specified in the contract. These rates may be adjusted only as a result of revisions to prevailing labor rates provided by the Secretary of Labor. The option provision may be exercised more than once, but the total extension of performance hereunder shall not exceed 6 months. The Contracting Officer may exercise the option by written notice to the Contractor within 60 days.

(End of Clause)

C.3 52.217-9 OPTION TO EXTEND THE TERM OF THE CONTRACT (MAR 2000)

(a) The Government may extend the term of this contract by written notice to the Contractor within 60 days; provided that the Government gives the Contractor a preliminary written notice of its intent to extend at least 30 days before the contract expires. The preliminary notice does not commit the Government to an extension.

(b) If the Government exercises this option, the extended contract shall be considered to include this option clause.

(c) The total duration of this contract, including the exercise of any options under this clause, shall not exceed Five Years 6 months.

(End of Clause) C.4 52.212-3 OFFEROR REPRESENTATIONS AND CERTIFICATIONS—COMMERCIAL ITEMS (OCT 2018) ALTERNATE I (OCT 2014) The Offeror shall complete only paragraph (b) of this provision if the Offeror has completed the annual representations and certification electronically in the System for Award Management (SAM) accessed through https://www.sam.gov. If the Offeror has not completed the annual representations and certifications electronically, the Offeror shall complete only paragraphs (c) through (u) of this provision.

(a) Definitions. As used in this provision— Economically disadvantaged women-owned small business (EDWOSB) concern means a small business concern that is at least 51 percent directly and unconditionally owned by, and the management and daily business operations of which are controlled by, one or more women who are citizens of the United States and who are economically disadvantaged in accordance with 13 CFR part 127. It automatically qualifies as a women-owned small business eligible under the WOSB Program.

Forced or indentured child labor means all work or service—

(1) Exacted from any person under the age of 18 under the menace of any penalty for its nonperformance and for which the worker does not offer himself voluntarily; or

(2) Performed by any person under the age of 18 pursuant to a contract the enforcement of which can be accomplished by process or penalties.

Highest-level owner means the entity that owns or controls an immediate owner of the offeror, or that owns or controls one or more entities that control an immediate owner of the offeror. No entity owns or exercises control of the highest level owner.

Immediate owner means an entity, other than the offeror, that has direct control of the offeror. Indicators of control include, but are not limited to, one or more of the following: Ownership or interlocking management, identity of interests among family members, shared facilities and equipment, and the common use of employees.

Inverted domestic corporation means a foreign incorporated entity that meets the definition of an inverted domestic corporation under 6 U.S.C. 395(b), applied in accordance with the rules and definitions of 6 U.S.C. 395(c).

Manufactured end product means any end product in product and service codes (PSCs) 1000-9999, except—

(1) PSC 5510, Lumber and Related Basic Wood Materials;

(2) Product or Service Group (PSG) 87, Agricultural Supplies;

(3) PSG 88, Live Animals;

(4) PSG 89, Subsistence;

(5) PSC 9410, Crude Grades of Plant Materials;

(6) PSC 9430, Miscellaneous Crude Animal Products, Inedible;

(7) PSC 9440, Miscellaneous Crude Agricultural and Forestry Products;

(8) PSC 9610, Ores;

(9) PSC 9620, Minerals, Natural and Synthetic; and

(10) PSC 9630, Additive Metal Materials.

Place of manufacture means the place where an end product is assembled out of components, or otherwise made or processed from raw materials into the finished product that is to be provided to the Government. If a product is disassembled and reassembled, the place of reassembly is not the place of manufacture.

Predecessor means an entity that is replaced by a successor and includes any predecessors of the predecessor.

Restricted business operations means business operations in Sudan that include power production activities, mineral extraction activities, oil-related activities, or the production of military equipment, as those terms are defined in the Sudan Accountability and Divestment Act of 2007 (Pub. L. 110-174). Restricted business operations do not include business operations that the person (as that term is defined in Section 2 of the Sudan Accountability and Divestment Act of 2007) conducting the business can demonstrate—

(1) Are conducted under contract directly and exclusively with the regional government of southern Sudan;

(2) Are conducted pursuant to specific authorization from the Office of Foreign Assets Control in the Department of the Treasury, or are expressly exempted under Federal law from the requirement to be conducted under such authorization;

(3) Consist of providing goods or services to marginalized populations of Sudan;

(4) Consist of providing goods or services to an internationally recognized peacekeeping force or humanitarian organization;

(5) Consist of providing goods or services that are used only to promote health or education; or

(6) Have been voluntarily suspended.

Sensitive technology—

(1) Means hardware, software, telecommunications equipment, or any other technology that is to be used specifically—

(i) To restrict the free flow of unbiased information in Iran; or

(ii) To disrupt, monitor, or otherwise restrict speech of the people of Iran; and

(2) Does not include information or informational materials the export of which the President does not have the authority to regulate or prohibit pursuant to section 203(b)(3) of the International Emergency Economic Powers Act (50 U.S.C. 1702(b)(3)).

Service-disabled veteran-owned small business concern—

(1) Means a small business concern—

(i) Not less than 51 percent of which is owned by one or more service-disabled veterans or, in the case of any publicly owned business, not less than 51 percent of the stock of which is owned by one or more service-disabled veterans; and

(ii) The management and daily business operations of which are controlled by one or more service-disabled veterans or, in the case of a service-disabled veteran with permanent and severe disability, the spouse or permanent caregiver of such veteran.

(2) Service-disabled veteran means a veteran, as defined in 38 U.S.C. 101(2), with a disability that is service-connected, as defined in 38 U.S.C. 101(16).

Small business concern means a concern, including its affiliates, that is independently owned and operated, not dominant in the field of operation in which it is bidding on Government contracts, and qualified as a small business under the criteria in 13 CFR Part 121 and size standards in this solicitation.

Small disadvantaged business concern, consistent with 13 CFR 124.1002, means a small business concern under the size standard applicable to the acquisition, that—

(1) Is at least 51 percent unconditionally and directly owned (as defined at 13 CFR 124.105) by—

(i) One or more socially disadvantaged (as defined at 13 CFR 124.103) and economically disadvantaged (as defined at 13 CFR 124.104) individuals who are citizens of the United States; and

(ii) Each individual claiming economic disadvantage has a net worth not exceeding $750,000 after taking into account the applicable exclusions set forth at 13 CFR 124.104(c)(2); and

(2) The management and daily business operations of which are controlled (as defined at 13.CFR 124.106) by individuals, who meet the criteria in paragraphs (1)(i) and (ii) of this definition.

Subsidiary means an entity in which more than 50 percent of the entity is owned—

(1) Directly by a parent corporation; or

(2) Through another subsidiary of a parent corporation.

Successor means an entity that has replaced a predecessor by acquiring the assets and carrying out the affairs of the predecessor under a new name (often through acquisition or merger). The term “successor” does not include new offices/divisions of the same company or a company that only changes its name. The extent of the responsibility of the successor for the liabilities of the predecessor may vary, depending on State law and specific circumstances.

Veteran-owned small business concern means a small business concern—

(1) Not less than 51 percent of which is owned by one or more veterans (as defined at 38 U.S.C. 101(2)) or, in the case of any publicly owned business, not less than 51 percent of the stock of which is owned by one or more veterans; and

(2) The management and daily business operations of which are controlled by one or more veterans.

Women-owned business concern means a concern which is at least 51 percent owned by one or more women; or in the case of any publicly owned business, at least 51 percent of its stock is owned by one or more women; and whose management and daily business operations are controlled by one or more women.

Women-owned small business concern means a small business concern—

(1) That is at least 51 percent owned by one or more women; or, in the case of any publicly owned business, at least 51 percent of the stock of which is owned by one or more women; and

(2) Whose management and daily business operations are controlled by one or more women.

Women-owned small business (WOSB) concern eligible under the WOSB Program (in accordance with 13 CFR part 127), means a small business concern that is at least 51 percent directly and unconditionally owned by, and the management and daily business operations of which are controlled by, one or more women who are citizens of the United States.

(b)(1) Annual Representations and Certifications. Any changes provided by the Offeror in paragraph (b)(2) of this provision do not automatically change the representations and certifications in SAM.

(2) The offeror has completed the annual representations and certifications electronically in SAM accessed through http://www.sam.gov. After reviewing SAM information, the Offeror verifies by submission of this offer that the representations and certifications currently posted electronically at FAR 52.212–3, Offeror Representations and Certifications— Commercial Items, have been entered or updated in the last 12 months, are current, accurate, complete, and applicable to this solicitation (including the business size standard applicable to the NAICS code referenced for this solicitation), at the time this offer is submitted and are incorporated in this offer by reference (see FAR 4.1201), except for paragraphs .

(c) Offerors must complete the following representations when the resulting contract will be performed in the United States or its outlying areas. Check all that apply.

(1) Small business concern. The offeror represents as part of its offer that it [ ] is, [ ] is not a small business concern.

(2) Veteran-owned small business concern. [Complete only if the offeror represented itself as a small business concern in paragraph (c)(1) of this provision.] The offeror represents as part of its offer that it [ ] is, [ ] is not a veteran-owned small business concern.

(3) Service-disabled veteran-owned small business concern. [Complete only if the offeror represented itself as a veteran-owned small business concern in paragraph (c)(2) of this provision.] The offeror represents as part of its offer that it [ ] is, [ ] is not a service-disabled veteran-owned small business concern.

(4) Small disadvantaged business concern. [Complete only if the offeror represented itself as a small business concern in paragraph (c)(1) of this provision.] The offeror represents that it [ ] is, [ ] is not a small disadvantaged business concern as defined in 13 CFR 124.1002.

(5) Women-owned small business concern. [Complete only if the offeror represented itself as a small business concern in paragraph (c)(1) of this provision.] The offeror represents that it [ ] is, [ ] is not a women-owned small business concern.

(6) WOSB concern eligible under the WOSB Program. [Complete only if the offeror represented itself as a women-owned small business concern in paragraph (c)(5) of this provision.] The offeror represents that—

(i) It [ ] is, [ ] is not a WOSB concern eligible under the WOSB Program, has provided all the required documents to the WOSB Repository, and no change in circumstances or adverse decisions have been issued that affects its eligibility; and

(ii) It [ ] is, [ ] is not a joint venture that complies with the requirements of 13 CFR part 127, and the representation in paragraph (c)(6)(i) of this provision is accurate for each WOSB concern eligible under the WOSB Program participating in the joint venture. [The offeror shall enter the name or names of the WOSB concern eligible under the WOSB Program and other small businesses that are participating in the joint venture: ___________.] Each WOSB concern eligible under the WOSB Program participating in the joint venture shall submit a separate signed copy of the WOSB representation.

(7) Economically disadvantaged women-owned small business (EDWOSB) concern. [Complete only if the offeror represented itself as a WOSB concern eligible under the WOSB Program in (c)(6) of this provision.] The offeror represents that—

(i) It [ ] is, [ ] is not an EDWOSB concern, has provided all the required documents to the WOSB Repository, and no change in circumstances or adverse decisions have been issued that affects its eligibility; and

(ii) It [ ] is, [ ] is not a joint venture that complies with the requirements of 13 CFR part 127, and the representation in paragraph (c)(7)(i) of this provision is accurate for each EDWOSB concern participating in the joint venture. [The offeror shall enter the name or names of the EDWOSB concern and other small businesses that are participating in the joint venture: ___________.] Each EDWOSB concern participating in the joint venture shall submit a separate signed copy of the EDWOSB representation.

Note: Complete paragraphs (c)(8) and (c)(9) only if this solicitation is expected to exceed the simplified acquisition threshold.

(8) Women-owned business concern (other than small business concern). [Complete only if the offeror is a women-owned business concern and did not represent itself as a small business concern in paragraph (c)(1) of this provision.] The offeror represents that it [ ] is a women-owned business concern.

(9) Tie bid priority for labor surplus area concerns. If this is an invitation for bid, small business offerors may identify the labor surplus areas in which costs to be incurred on account of manufacturing or production (by offeror or first-tier subcontractors) amount to more than 50 percent of the contract price:

(10) HUBZone small business concern. [Complete only if the offeror represented itself as a small business concern in paragraph (c)(1) of this provision.] The offeror represents, as part of its offer, that—

(i) It [ ] is, [ ] is not a HUBZone small business concern listed, on the date of this representation, on the List of Qualified HUBZone Small Business Concerns maintained by the Small Business Administration, and no material change in ownership and control, principal office, or HUBZone employee percentage has occurred since it was certified by the Small Business Administration in accordance with 13 CFR Part 126; and

(ii) It [ ] is, [ ] is not a joint venture that complies with the requirements of 13 CFR Part 126, and the representation in paragraph (c)(10)(i) of this provision is accurate for the HUBZone small business concern or concerns that are participating in the joint venture. [The offeror shall enter the name or names of the HUBZone small business concern or concerns that are participating in the joint venture:____________.] Each HUBZone small business concern participating in the joint venture shall submit a separate signed copy of the HUBZone representation.

(11) (Complete if the offeror has represented itself as disadvantaged in paragraph (c)(4) of this provision.)

[The offeror shall check the category in which its ownership falls]:

____ Black American.

____ Hispanic American.

____ Native American (American Indians, Eskimos, Aleuts, or Native Hawaiians).

____ Asian-Pacific American (persons with origins from Burma, Thailand, Malaysia, Indonesia, Singapore, Brunei, Japan, China, Taiwan, Laos, Cambodia (Kampuchea), Vietnam, Korea, The Philippines, Republic of Palau, Republic of the Marshall Islands, Federated States of Micronesia, the Commonwealth of the Northern Mariana Islands, Guam, Samoa, Macao, Hong Kong, Fiji, Tonga, Kiribati, Tuvalu, or Nauru).

____ Subcontinent Asian (Asian-Indian) American (persons with origins from India, Pakistan, Bangladesh, Sri Lanka, Bhutan, the Maldives Islands, or Nepal).

____ Individual/concern, other than one of the preceding.

(d) Representations required to implement provisions of Executive Order 11246—

(1) Previous contracts and compliance. The offeror represents that—

(i) It [ ] has, [ ] has not participated in a previous contract or subcontract subject to the Equal Opportunity clause of this solicitation; and

(ii) It [ ] has, [ ] has not filed all required compliance reports.

(2) Affirmative Action Compliance. The offeror represents that—

(i) It [ ] has developed and has on file, [ ] has not developed and does not have on file, at each establishment, affirmative action programs required by rules and regulations of the Secretary of Labor (41 CFR parts 60-1 and 60-2), or

(ii) It [ ] has not previously had contracts subject to the written affirmative action programs requirement of the rules and regulations of the Secretary of Labor.

(e) Certification Regarding Payments to Influence Federal Transactions (31 U.S.C. 1352). (Applies only if the contract is expected to exceed $150,000.) By submission of its offer, the offeror certifies to the best of its knowledge and belief that no Federal appropriated funds have been paid or will be paid to any person for influencing or attempting to influence an officer or employee of any agency, a Member of Congress, an officer or employee of Congress or an employee of a Member of Congress on his or her behalf in connection with the award of any resultant contract. If any registrants under the Lobbying Disclosure Act of 1995 have made a lobbying contact on behalf of the offeror with respect to this contract, the offeror shall complete and submit, with its offer, OMB Standard Form LLL, Disclosure of Lobbying Activities, to provide the name of the registrants. The offeror need not report regularly employed officers or employees of the offeror to whom payments of reasonable compensation were made.

(f) Buy American Certificate. (Applies only if the clause at Federal Acquisition Regulation (FAR) 52.225-1, Buy American—Supplies, is included in this solicitation.)

(1) The offeror certifies that each end product, except those listed in paragraph (f)(2) of this provision, is a domestic end product and that for other than COTS items, the offeror has considered components of unknown origin to have been mined, produced, or manufactured outside the United States. The offeror shall list as foreign end products those end products manufactured in the United States that do not qualify as domestic end products, i.e., an end product that is not a COTS item and does not meet the component test in paragraph (2) of the definition of “domestic end product.” The terms “commercially available off-the-shelf (COTS) item,” “component,” “domestic end product,” “end product,” “foreign end product,” and “United States” are defined in the clause of this solicitation entitled “Buy American—Supplies.”

(2) Foreign End Products:

Line Item No Country of Origin [List as necessary]

(3) The Government will evaluate offers in accordance with the policies and procedures of FAR Part 25.

(g)(1) Buy American—Free Trade Agreements—Israeli Trade Act Certificate. (Applies only if the clause at FAR 52.225-3, Buy American—Free Trade Agreements—Israeli Trade Act, is included in this solicitation.)

(i) The offeror certifies that each end product, except those listed in paragraph (g)(1)(ii) or (g)(1)(iii) of this provision, is a domestic end product and that for other than COTS items, the offeror has considered components of unknown origin to have been mined, produced, or manufactured outside the United States. The terms “Bahrainian, Moroccan, Omani, Panamanian, or Peruvian end product,” “commercially available off-the-shelf (COTS) item,” “component,” “domestic end product,” “end product,” “foreign end product,” “Free Trade Agreement country,” “Free Trade Agreement country end product,” “Israeli end product,” and “United States” are defined in the clause of this solicitation entitled “Buy American—Free Trade Agreements—Israeli Trade Act.”

(ii) The offeror certifies that the following supplies are Free Trade Agreement country end products (other than Bahrainian, Moroccan, Omani, Panamanian, or Peruvian end products) or Israeli end products as defined in the clause of this solicitation entitled “Buy American—Free Trade Agreements—Israeli Trade Act”:

Free Trade Agreement Country End Products (Other than Bahrainian, Moroccan, Omani, Panamanian, or Peruvian End Products) or Israeli End Products:

Line Item No. Country of Origin [List as necessary]

(iii) The offeror shall list those supplies that are foreign end products (other than those listed in paragraph (g)(1)(ii) of this provision) as defined in the clause of this solicitation entitled “Buy American—Free Trade Agreements—Israeli Trade Act.” The offeror shall list as other foreign end products those end products manufactured in the United States that do not qualify as domestic end products, i.e., an end product that is not a COTS item and does not meet the component test in paragraph (2) of the definition of “domestic end product.”

Other Foreign End Products:

Line Item No. Country of Origin [List as necessary]

(iv) The Government will evaluate offers in accordance with the policies and procedures of FAR Part 25.

(2) Buy American—Free Trade Agreements—Israeli Trade Act Certificate, Alternate I. If Alternate I to the clause at FAR 52.225-3 is included in this solicitation, substitute the following paragraph (g)(1)(ii) for paragraph (g)(1)(ii) of the basic provision:

(g)(1)(ii) The offeror certifies that the following supplies are Canadian end products as defined in the clause of this solicitation entitled “Buy American—Free Trade Agreements—Israeli Trade Act”:

Canadian End Products:

Line Item No.

[List as necessary]

(3) Buy American—Free Trade Agreements—Israeli Trade Act Certificate, Alternate II. If Alternate II to the clause at FAR 52.225-3 is included in this solicitation, substitute the following paragraph (g)(1)(ii) for paragraph (g)(1)(ii) of the basic provision:

(g)(1)(ii) The offeror certifies that the following supplies are Canadian end products or Israeli end products as defined in the clause of this solicitation entitled “Buy American—Free Trade Agreements—Israeli Trade Act”:

Canadian or Israeli End Products:

Line Item No. Country of Origin [List as necessary]

(4) Buy American—Free Trade Agreements—Israeli Trade Act Certificate, Alternate III. If Alternate III to the clause at FAR 52.225-3 is included in this solicitation, substitute the following paragraph (g)(1)(ii) for paragraph (g)(1)(ii) of the basic provision:

(g)(1)(ii) The offeror certifies that the following supplies are Free Trade Agreement country end products (other than Bahrainian, Korean, Moroccan, Omani, Panamanian, or Peruvian end products) or Israeli end products as defined in the clause of this solicitation entitled “Buy American—Free Trade Agreements—Israeli Trade Act”:

Free Trade Agreement Country End Products (Other than Bahrainian, Korean, Moroccan, Omani, Panamanian, or Peruvian End Products) or Israeli End Products:

Line Item No. Country of Origin [List as necessary]

(5) Trade Agreements Certificate.

This is the start of the file's text. The full file is on GovTribe.

File details come from the government source that posted it.